secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001213900-24-011587
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma subsidiary acquires psoriasis patent for $1.5M in stock
--------------------------------------------------------------------

- Helpson, a wholly owned subsidiary of China Pharma, entered a Technology Transfer Agreement with Lihua Li to acquire an invention patent for a psoriasis treatment.
- Total consideration is $1.5 million, paid via 15 million restricted shares of common stock at $0.10 per share to the transferor and two designees.
- If the product launches and generates profit within 10 years, Helpson will pay 10% of annual net profit in cash to the transferor.
- Shares will be issued in an offshore transaction exempt from registration under Regulation S of the Securities Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/0001213900-24-011587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390024011587/ea193188-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-011587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer